Cargando…
Innovative Therapeutic Approaches in Primary Cutaneous B Cell Lymphoma
Background: Primary cutaneous B-cell lymphomas (pCBCL) include an infrequent group of non-Hodgkin lymphomas that are limited to skin sites at the time of diagnosis. They comprise roughly 20–25% of all cutaneous lymphomas and are subdivided into primary cutaneous marginal zone lymphoma (PCMZL), prima...
Autores principales: | Lang, Claudia C. V., Ramelyte, Egle, Dummer, Reinhard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7426470/ https://www.ncbi.nlm.nih.gov/pubmed/32850331 http://dx.doi.org/10.3389/fonc.2020.01163 |
Ejemplares similares
-
What Is New in Cutaneous T Cell Lymphoma?
por: Morgenroth, Sarah, et al.
Publicado: (2023) -
Recurrent squamous cell carcinoma of the perianal skin: a case report
por: Staeger, Ramon, et al.
Publicado: (2020) -
Primary Cutaneous B-Cell Lymphomas: An Update
por: Vitiello, Paola, et al.
Publicado: (2020) -
The role of triple therapy and therapy sequence in treatment of BRAF-mutant metastatic melanoma. Response to overall survival with first-line atezolizumab in combination with vemurafenib and cobimetinib in BRAFV600 mutation-positive advanced melanoma (IMspire150): second interim analysis of a multicentre, randomised, phase 3 study
por: Dummer, Reinhard, et al.
Publicado: (2023) -
Diagnostic Workup of Primary Cutaneous B Cell Lymphomas: A Clinician's Approach
por: Tadiotto Cicogna, Giulia, et al.
Publicado: (2020)